Vitalis Therapeutics, Inc. — Form D
Vitalis Therapeutics, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-19. The offering totals $3.0M, of which $2.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-02-19
- Form: D
- Accession: 0000929638-25-000820
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $2.0M
- Remaining: $1.1M
- Investors: 14
- Date of first sale: 2022-12-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-538561
Issuer
- Name: Vitalis Therapeutics, Inc.
- CIK: 0002026886
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 93 4TH AVENUE, #19, NEW YORK, NY, 10003
- Phone: 646-831-7338
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| Joseph Habboushe | Director | New York, NY |
| Joseph Habboushe | Executive Officer | New York, NY |
More